A bill that includes a provision co-authored by U.S. Sen. Susan Collins to lower drug prices awaits President Donald Trump’s signature. The provision, part of the Food and Drug Administration’s Reauthorization Act, seeks to keep prescription drug prices down by speeding up timelines and inspection procedures for the FDA’s review of applications for generic drug […]
Maine lawmakers still cannot agree on bonds, campaign finance fix
Mills won the Democratic primary, but did ranked-choice voting work?
Sins at the southern border will haunt our country
Susan Collins opposes bill focused on stopping taking children from asylum seekers